Skip to main content
. 2007 May 15;64(4):510–516. doi: 10.1111/j.1365-2125.2007.02901.x

Table 1.

Distribution of treatment according to gestational months

Gestational months
Ergotamine products 1 2 3 4 5 6 7 8 9 Total
Ergotamine drops n 10 7 7 5 3 3 7 4 9 55
% 18.2 12.7 12.7 9.1 5.5 5.5 12.7 7.3 16.4 100
Kefalgin® n 10 6 3 1 1 1 0 0 0 22
% 45.5 27.3 13.6 4.5 4.5 4.5 0.0 0.0 0.0 100